BIOXBasic Materials · Agricultural InputsTicker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 27 of 100 as at 19 Sept 2026 — in the lower half.
Consensus tells you what everyone already believes. The model scores Bioceres Crop Solutions Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Issuance (91): The share count has been shrinking and the company is not leaning on new borrowing.
Momentum (7): The shares have been drifting down relative to others.
Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.
The bullish and bearish analyst opinions on BIOX, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 2 Jan 2026 | Canaccord Genuity | Maintains | Hold | $2.25 → $2.00 |
| 2 Jan 2026 | Canaccord Genuity | Maintains | Hold | — |
| 14 Nov 2025 | Canaccord Genuity | Maintains | Hold | — |
| 10 Sept 2025 | Canaccord Genuity | Downgrade | Hold | — |
| 10 Sept 2025 | Lake Street | Maintains | Buy | — |
| 15 July 2025 | Oppenheimer | Maintains | Outperform | — |
| 22 Apr 2025 | Oppenheimer | Maintains | Outperform | — |
| 13 Feb 2025 | Canaccord Genuity | Maintains | Buy | — |
| 7 Feb 2025 | Canaccord Genuity | Maintains | Buy | — |
| 7 Feb 2025 | Lake Street | Maintains | Buy | — |
| 28 Jan 2025 | Oppenheimer | Maintains | Outperform | — |
| 13 Nov 2024 | Canaccord Genuity | Maintains | Buy | — |
| 21 Oct 2024 | Oppenheimer | Maintains | Outperform | — |
| 17 Oct 2024 | Canaccord Genuity | Maintains | Buy | — |
| 11 Sept 2024 | Canaccord Genuity | Maintains | Buy | — |
| 11 Sept 2024 | Lake Street | Maintains | Buy | — |
| 11 Sept 2024 | Oppenheimer | Maintains | Outperform | — |
| 11 Sept 2024 | Roth MKM | Maintains | Buy | — |
| 19 July 2024 | Canaccord Genuity | Assumes | Buy | $17 |
| 2 July 2024 | Roth MKM | Reinstates | Buy | $15 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BIOX appears on the weeks it earns a place.
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 18 Sept 2026, Bioceres Crop Solutions Corp. returned −79.6% against +16.3% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 3% of US stocks
Cheaper than 96% of US stocks
Cheaper than 90% of US stocks
Cheaper than 18% of US stocks
Higher than 10% of US stocks
Higher than 14% of US stocks
Higher than 39% of US stocks
Higher than 22% of US stocks
Higher than 16% of US stocks
Higher than 28% of US stocks
Higher than 43% of US stocks
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Bioceres Crop Solutions Corp. has a market value of $23.0M and an enterprise value of $272.5M.
Revenue in the twelve months to 31 Mar 2026: $263.7M. The latest quarter shrank 23.4% year on year.
Net income over the same four quarters: −$251.6M, a −95.4% net margin.
Diluted earnings per share, trailing twelve months: $−3.84.
Trailing P/E: 227.0×; forward P/E: 0.6× — the forward figure prices analyst consensus estimates, not reported earnings.
Bioceres Crop Solutions Corp. employs 751 people — $351K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| BIOXBioceres Crop Solutions Corp. | $23.0M | 27 |
| SEEDOrigin Agritech Ltd. | $11.3M | 22 |
| AVDAmerican Vanguard Corp. | $62.1M | 34 |
| NXTSNexentis Technologies, Inc. | $1.9M | 3 |
| LOOPLoop Industries, Inc.* | $24.8M | 14 |
| IPIIntrepid Potash, Inc. | $504.5M | 93 |
| MERCMercer International, Inc.* | $25.3M | 8 |
* Nearest Basic Materials names by size — few agricultural inputs companies of this scale trade in the US universe.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own Bioceres Crop Solutions Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Seeking Alpha published the transcript of Bioceres Crop Solutions Corp.'s Q4 2026 earnings call. The item presents the full transcript of management's earnings discussion for the quarter.
Why it matters — BIOX watchers would look to this transcript for management's own commentary on the company's fourth-quarter results and outlook.
Bioceres Crop Solutions Corp. announced its financial results for the fiscal fourth quarter ended June 30, 2026, as well as full-year results. The figures are expressed in U.S. dollars and presented in accordance with International Financial Reporting Standards.
Why it matters — BIOX watchers would want to review the company's latest quarterly and annual financial results to assess its recent performance.
Bioceres Crop Solutions Corp. will host a conference call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time to discuss its financial results for the fiscal fourth quarter and full year ended June 30, 2026. A press release detailing these results will accompany the call.
Why it matters — BIOX watchers will want to tune in for the company's fiscal fourth quarter and full year results, which provide the latest update on its performance and outlook.
Of the 1 analysts covering Bioceres Crop Solutions Corp., 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Bioceres Crop Solutions Corp. 27 out of 100 across roughly 4,600 US stocks as at 19 Sept 2026. None of this is personal advice — it does not consider your circumstances.
As at 19 Sept 2026, Bioceres Crop Solutions Corp. ranks 27 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Issuance (91 of 100).
No analyst covering Bioceres Crop Solutions Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BIOX are extrapolating price history, which says nothing about the business.
Bioceres Crop Solutions Corp. returned -79.6% over the 12 months to 18 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.
Bioceres Crop Solutions Corp. is an agricultural biotechnology company that develops and commercializes crop productivity solutions for farmers and agribusinesses.
The most recent item we track (Seeking Alpha, 15 Sept 2026): "Bioceres Crop Solutions Corp. (BIOX) Q4 2026 Earnings Call Transcript". Seeking Alpha published the transcript of Bioceres Crop Solutions Corp.'s Q4 2026 earnings call. The item presents the full transcript of management's earnings discussion for the quarter.
Bioceres Crop Solutions Corp. is an agricultural biotechnology company that develops and commercializes crop productivity solutions for farmers and agribusinesses. Its portfolio includes seeds, seed traits, seed treatments, biological inputs, crop protection products, and crop nutrition solutions designed to improve crop performance and resilience. The company operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments, giving it a broad platform across the agricultural input value chain. Bioceres Crop Solutions also offers HB4 drought-tolerant seed technology, supporting crops used in major row-crop markets. With operations and product sales across multiple regions, the company serves customers in South America, North America, Europe, Africa, and other international markets. Bioceres Crop Solutions Corp. plays a role in modern agriculture by combining biotechnology, biologicals, and input technologies to support more efficient crop production.
CEO Dr. Federico Trucco Ph.D. · 751 employees · Argentina · https://investors.biocerescrops.com/home/default.aspx
